Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tournier

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neuroscience Research|January 1, 1988
Human T-cell response to myelin basic protein in multiple sclerosis patients and healthy subjectsE Tournier-Lasserve, G A Hashim, M A Bach
Medical Progress Through Technology|January 1, 1991
Interest of TOF PET for clinical applicationsJ Vacher, R Allemand, A Bouvier, et al.
Acta Neurologica Scandinavica|July 1, 1986
Comparison of the response to phytohemagglutinin, of peripheral blood mononuclear cells and cerebrospinal fluid lymphocytes in multiple sclerosis and other neurological diseases. Determination of the frequency of the precursor cells by a limiting dilution analysisE Tournier-Lasserve, E Roullet, O Lyoncaen, et al.
Clinical and Experimental Immunology|March 1, 1987
IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseasesE Tournier-Lasserve, O Lyoncaen, E Roullet, et al.
European Journal of Neurology|April 30, 2020
CADASIL: yesterday, today, tomorrowH Chabriat, A Joutel, E Tournier-Lasserve, et al.
Pathologie-Biologie|March 1, 1987
[Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases]E Tournier-Lasserve, O Lyon-Caen, E Roullet, et al.
European Journal of Human Genetics : EJHG|June 3, 1999
Genetic heterogeneity and absence of founder effect in a series of 36 French cerebral cavernous angiomas familiesS Laberge, P Labauge, E Maréchal, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1996
Prevalence of serum antibodies to hepatitis C virus is not increased in patients with multiple sclerosisO Heinzlef, E Roullet, C Johanet, et al.
Lancet (London, England)|December 24, 1998
Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de NeurochirurgieP Labauge, S Laberge, L Brunereau, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 30, 2009
Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhoodP Bertholon, S Chabrier, F Riant, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neuroscience Research|January 1, 1988
Human T-cell response to myelin basic protein in multiple sclerosis patients and healthy subjectsE Tournier-Lasserve, G A Hashim, M A Bach
Medical Progress Through Technology|January 1, 1991
Interest of TOF PET for clinical applicationsJ Vacher, R Allemand, A Bouvier, et al.
Acta Neurologica Scandinavica|July 1, 1986
Comparison of the response to phytohemagglutinin, of peripheral blood mononuclear cells and cerebrospinal fluid lymphocytes in multiple sclerosis and other neurological diseases. Determination of the frequency of the precursor cells by a limiting dilution analysisE Tournier-Lasserve, E Roullet, O Lyoncaen, et al.
Clinical and Experimental Immunology|March 1, 1987
IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseasesE Tournier-Lasserve, O Lyoncaen, E Roullet, et al.
European Journal of Neurology|April 30, 2020
CADASIL: yesterday, today, tomorrowH Chabriat, A Joutel, E Tournier-Lasserve, et al.
Pathologie-Biologie|March 1, 1987
[Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases]E Tournier-Lasserve, O Lyon-Caen, E Roullet, et al.
European Journal of Human Genetics : EJHG|June 3, 1999
Genetic heterogeneity and absence of founder effect in a series of 36 French cerebral cavernous angiomas familiesS Laberge, P Labauge, E Maréchal, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1996
Prevalence of serum antibodies to hepatitis C virus is not increased in patients with multiple sclerosisO Heinzlef, E Roullet, C Johanet, et al.
Lancet (London, England)|December 24, 1998
Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de NeurochirurgieP Labauge, S Laberge, L Brunereau, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 30, 2009
Episodic ataxia type 2: unusual aspects in clinical and genetic presentation. Special emphasis in childhoodP Bertholon, S Chabrier, F Riant, et al.
Pageof 16